✦ LIBER ✦

A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis

✍ Scribed by K. LUOMANMÄKI; S. GRANKVIST; C. HALLERT; I. JAURO; K. KETOLA; H. C. KIM; H. KIVINIEMI; H. KOSKIVIRTA; L. SÖRSKOG; P. VILKKO

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of subcutaneous low-molecular

✍ P. Prandoni; M. Carta; A. Cogo; A. Ruol; M. Vigo; D. Casara; A.W.A. Lensing; H.R 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 686 KB

Use of low molecular weight heparin (dal

✍ P. LINDMARKER; M. HOLMSTRÖM; Swedish Venous Thrombosis Dalteparin Trial Group 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Low-Molecular-Weight Heparin in the Init

✍ Karen Aileen Valentine; Graham Frederick Pineo; Russell Douglas Hull 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 147 KB

Dose adjusted heparin treatment of deep

✍ G. F. Handeland; U. Abildgaard; H. A. Holm; K. E. Arnesen 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 645 KB

Ximelagatran vs. Low-Molecular-Weight He

✍ J.N. Fiessinger; M.V. Huisman; B.L. Davidson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Low molecular weight heparin once daily

✍ Dr. D. Bergqvist; Ulla Stina Burmark; J. Frisell; T. Hallböök; B. Lindblad; B. R 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB